Chemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis l-aspartate α-decarboxylase

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Sharma, Reetu ^a   Kothapalli, Roopa ^a   van Dongen, Antonius M J ^a   Swaminathan, Kunchithapadam ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

1H PYRAZOLO[3,4 D]PYRIMIDIN 4(7H) ONE; 2 (HYDROXYMETHYL) TETRAHYDRO 2H PYRAN 2,3,4,5 TETRAOL; 2,3,4,6 TETRAHYDROXY 5 MERCAPTOHEXANAL; 2,5 BIS(HYDROXYMETHYL)TETRAHYDROFURAN 2,3,4 TRIOL; 3 AMINO 4 (PROPYLAMINO) CYCLOBUTANE 1,2 DIONE; 5 ACETOXY 4 METHYLPENTANOIC ACID; ASPARAGINE; ASPARTATE ALPHA DECARBOXYLASE INHIBITOR; ENZYME INHIBITOR; FUMARIC ACID; ISOASPARAGINE; S ADENOSYLMETHIONINE; TETRAHYDRO 2H PYRAN 2,3,4,5 TETRAOL; THIAZOLIDIN 3 IUM 4 CARBOXYLIC ACID; UNCLASSIFIED DRUG; ASPARTATE ALPHA DECARBOXYLASE; ASPARTATE-ALPHA-DECARBOXYLASE; GLUTAMATE DECARBOXYLASE;

ARTICLE; COMPLEX FORMATION; CROSS REACTION; CRYSTALLOGRAPHY; DRUG ABSORPTION; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYSICAL CHEMISTRY; TOXICITY TESTING; BINDING SITE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FACTUAL DATABASE; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANIMALIA; FUNGI; MYCOBACTERIUM TUBERCULOSIS;

BINDING SITES; COMPUTER SIMULATION; DATABASES, FACTUAL; ENZYME INHIBITORS; GLUTAMATE DECARBOXYLASE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN STRUCTURE, TERTIARY; SOFTWARE;

EID: 84859026548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033521     Document Type: Article

References (37)

1. Cronan JE, (1980) Beta-alanine synthesis in Escherichia coli. J Bacteriol 141: 1291-1297.
2. Sassetti CM, Boyd DH, Rubin EJ, (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Molecular Microbiology 48: 77-84.
3. Spry C, Kirk K, Saliba KJ, (2008) Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiology Reviews 32: 56-106.
4. The World Health Report (1997) The World Health Organization, Geneva, Switzerland.
5. Cox JS, Chen B, McNeil M, Jacobs WR, (1999) Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402: 79-83.
6. Daffé M, Draper P, (1997) The envelope layers of mycobacteria with reference to their pathogenicity. In: Poole RK, editors. Academic Press pp. 131-203.
7. Glickman MS, Cox JS, Jacobs WR, (2000) A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Molecular cell 5: 717-727.
8. Karakousis PC, (2009) Mechanisms of action and resistance of antimycobacterial agents. In: Mayers DL, editors. Humana Press pp. 271-291.
9. Jackowski S, (1996) Escherichia coli and Salmonella: cellular and molecular biology; In: Neidhardt FC, Umbarger HE, editors. Washington DC American Society for Microbiology Press.
10. Ramjee MK, Genschel U, Abell C, Smith AG, (1997) Escherichia coli L-aspartate-alpha-decarboxylase: preprotein processing and observation of reaction intermediates by electrospray mass spectrometry. Biochem J 323 (Pt 3): 661-669.
11. Kennedy J, (2004) Tools for metabolic engineering in Escherichia coli: inactivation of panD by a point mutation. Analytical Biochemistry 327: 91-96.
12. Schmitzberger F, Kilkenny ML, Lobley CM, Webb ME, Vinkovic M, et al. (2003) Structural constraints on protein self-processing in L-aspartate-alpha-decarboxylase. EMBO J 22: 6193-6204.
13. Gopalan G, Chopra S, Ranganathan A, Swaminathan K, (2006) Crystal structure of uncleaved L-aspartate-alpha-decarboxylase from Mycobacterium tuberculosis. Proteins 65: 796-802.
14. Albert A, Dhanaraj V, Genschel U, Khan G, Ramjee MK, et al. (1998) Crystal structure of aspartate decarboxylase at 2.2 A resolution provides evidence for an ester in protein self-processing. Nat Struct Mol Biol 5: 289-293.
15. Lee BI, Suh SW, (2004) Crystal structure of the schiff base intermediate prior to decarboxylation in the catalytic cycle of aspartate alpha-decarboxylase. J Mol Biol 340: 1-7.
16. Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, et al. (2002) A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 8: 1171-1174.
17. Williamson JM, Brown GM, (1979) Purification and properties of L-aspartate-alpha-decarboxylase, an enzyme that catalyzes the formation of beta-alanine in Escherichia coli. J Biol Chem 254: 8074-8082.
18. Williamson JM, (1985) L-Aspartate alpha-decarboxylase. Methods Enzymol 113: 589-595.
19. Webb ME, Smith AG, Abell C, (2004) Biosynthesis of pantothenate. Nat Prod Rep 21: 695-721.
20. Ravel JM, Shive W, (1946) Biochemical transformations as determined by competitive analogue-metabolite growth inhibitors. Journal of Biological Chemistry 166: 407-415.
21. Shive W, Macow J, (1946) Biochemical transformations as determined by competitive analogue-metabolite growth inhibitors. Journal of Biological Chemistry 162: 451-462.
22. Chopra S, Pai H, Ranganathan A, (2002) Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD. Protein Expression and Purification 25: 533-540.
23. Shatsky M, Nussinov R, Wolfson HJ, (2002) MultiProt- a multiple protein structural alignment algorithm Springer-Verlag pp. 235-250.
24. DeLano WL, (2002) The Pymol molecular graphics system. The Pymol molecular graphics system.
25. Jorgensen WL, Maxwell DS, Tirado-Rives J, (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society 118: 11225-11236.
26. Protein Preparation Wizard Maestro (2009) New York Schrödinger LLC.
27. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, et al. (2004) Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. Journal of Medicinal Chemistry 47: 1750-1759.
28. Irwin JJ, Shoichet BK, (2005) ZINC - a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling 45: 177-182.
29. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ, (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23: 3-25.
30. Jorgensen WL, (2006) Qikprop. v 3.0 ed New York Schrödinger LLC.
31. Recsei PA, Snell EE, (1984) Pyruvoyl enzymes. Annual Review of Biochemistry 53: 357-387.
32. Bale S, Brooks W, Hanes JW, Mahesan AM, Guida WC, et al. (2009) Role of the sulfonium center in determining the ligand specificity of human S-adenosylmethionine decarboxylase. Biochemistry 48: 6423-6430.
33. Saldanha SA, Birch LM, Webb ME, Nabbs BK, von Delft F, et al. (2001) Identification of Tyr58 as the proton donor in the aspartate-alpha-decarboxylase reaction. Chem Commun (Camb) pp. 1760-1761.
34. Webb ME, Stephens E, Smith AG, Abell C, (2003) Rapid screening by MALDI-TOF mass spectrometry to probe binding specificity at enzyme active sites. Chem Commun pp. 2416-2417.
35. Andreu N, Fletcher T, Krishnan N, Wiles S, Robertson BD, (2012) Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence. J Antimicrob Chemother 67: 404-414.
36. Kraulis P, (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. Journal of Applied Crystallography 24: 946-950.
37. Merritt EA, Bacon DJ, (1997) Raster3D Photorealistic Molecular Graphics. Methods Enzymol 277: 19.